Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Phase 2 Study for Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

NCT03994406 is registered in ClinicalTrials.gov with Glia, LLC as lead sponsor.

NCT NCT03994406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Phase 2 Study for Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
Lead sponsor
Glia, LLC
Phase
Phase 2
Overall status
Completed
Start date
June 27, 2019
Completion date
October 30, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contact lens acute red eye, contact lens discomfort, contact lens-induced corneal disorder, contact lens-induced corneal fluorescein staining